#METABOLOMICS WORKBENCH krjonscher_20220420_084738 DATATRACK_ID:3208 STUDY_ID:ST002192 ANALYSIS_ID:AN003588 PROJECT_ID:PR001389
VERSION             	1
CREATED_ON             	June 2, 2022, 7:25 am
#PROJECT
PR:PROJECT_TITLE                 	Protective effects of maternal PQQ on hepatic lipid metabolism throughout the
PR:PROJECT_TITLE                 	lifespan: Adult Study
PR:PROJECT_TYPE                  	Diet study and fetal programming
PR:PROJECT_SUMMARY               	Maternal obesity and consumption of a high-fat diet significantly elevate risk
PR:PROJECT_SUMMARY               	for pediatric non-alcoholic fatty liver disease (NAFLD), affecting 10% of
PR:PROJECT_SUMMARY               	children in the US. Almost half of these children are diagnosed with
PR:PROJECT_SUMMARY               	nonalcoholic steatohepatitis (NASH), a leading etiology for liver transplant.
PR:PROJECT_SUMMARY               	Animal models show that signs of liver injury and perturbed lipid metabolism
PR:PROJECT_SUMMARY               	asso-ciated with NAFLD begin in utero; however, safe dietary therapeutics to
PR:PROJECT_SUMMARY               	blunt developmental programming of NAFLD are unavailable. Using a mouse model of
PR:PROJECT_SUMMARY               	maternal Western-style diet (WD), we previously showed that pyrroloquinoline
PR:PROJECT_SUMMARY               	quinone (PQQ), a potent dietary antioxidant, protected offspring of WD-fed dams
PR:PROJECT_SUMMARY               	from development of NAFLD and NASH. Here, we used untargeted mass
PR:PROJECT_SUMMARY               	spectrometry-based lipidomics to delineate lipotoxic effects of WD on offspring
PR:PROJECT_SUMMARY               	liver and identify lipid targets of PQQ. PQQ exposure during pregnancy altered
PR:PROJECT_SUMMARY               	hepatic lipid profiles of WD-exposed offspring, upregulating peroxisome
PR:PROJECT_SUMMARY               	proliferator-activated receptor (PPAR) α signaling and mitochondrial fatty acid
PR:PROJECT_SUMMARY               	oxidation to markedly attenuate triglyceride accumulation beginning in utero.
PR:PROJECT_SUMMARY               	Surprisingly, the abundance of very long-chain ceramides, important in promoting
PR:PROJECT_SUMMARY               	gut barrier and hepatic function, was significantly elevated in PQQ-treated
PR:PROJECT_SUMMARY               	offspring. PQQ exposure reduced the hepatic
PR:PROJECT_SUMMARY               	phosphatidylcho-line/phosphatidylethanolamine (PC/PE) ratio in WD-fed offspring
PR:PROJECT_SUMMARY               	and improved glucose toler-ance. Notably, levels of protective n − 3
PR:PROJECT_SUMMARY               	polyunsaturated fatty acids (PUFAs) were elevated in offspring exposed to PQQ,
PR:PROJECT_SUMMARY               	beginning in utero, and the increase in n − 3 PUFAs persisted into adulthood.
PR:PROJECT_SUMMARY               	Our findings suggest that PQQ supplementation during gestation and lactation
PR:PROJECT_SUMMARY               	augments pathways involved in the biosynthesis of long-chain fatty acids and
PR:PROJECT_SUMMARY               	plays a unique role in modifying specific bioactive lipid species critical for
PR:PROJECT_SUMMARY               	protection against NAFLD risk in later life.
PR:INSTITUTE                     	University of Oklahoma Health Sciences Center
PR:DEPARTMENT                    	Biochemistry and Molecular Biology, Harold Hamm Diabetes Center
PR:LABORATORY                    	Jonscher
PR:LAST_NAME                     	Jonscher
PR:FIRST_NAME                    	Karen
PR:ADDRESS                       	975 NE 10th Street BRC-N 362A, Oklahoma City, OK, 73104, USA
PR:EMAIL                         	karen-jonscher@ouhsc.edu
PR:PHONE                         	3032294620
PR:FUNDING_SOURCE                	NIDDK
#STUDY
ST:STUDY_TITLE                   	Amelioration of developmental programming of NAFLD in adult liver using PQQ
ST:STUDY_TYPE                    	Pre-natal and Post-natal Diet and PQQ treatment
ST:STUDY_SUMMARY                 	Maternal obesity and consumption of a high-fat diet significantly elevate risk
ST:STUDY_SUMMARY                 	for pediatric non-alcoholic fatty liver disease (NAFLD), affecting 10% of
ST:STUDY_SUMMARY                 	children in the US. Almost half of these children are diagnosed with
ST:STUDY_SUMMARY                 	nonalcoholic steatohepatitis (NASH), a leading etiology for liver transplant.
ST:STUDY_SUMMARY                 	Animal models show that signs of liver injury and perturbed lipid metabolism
ST:STUDY_SUMMARY                 	asso-ciated with NAFLD begin in utero; however, safe dietary therapeutics to
ST:STUDY_SUMMARY                 	blunt developmental programming of NAFLD are unavailable. Using a mouse model of
ST:STUDY_SUMMARY                 	maternal Western-style diet (WD), we previously showed that pyrroloquinoline
ST:STUDY_SUMMARY                 	quinone (PQQ), a potent dietary antioxidant, protected offspring of WD-fed dams
ST:STUDY_SUMMARY                 	from development of NAFLD and NASH. Here, we used untargeted mass
ST:STUDY_SUMMARY                 	spectrometry-based lipidomics to delineate lipotoxic effects of WD on offspring
ST:STUDY_SUMMARY                 	liver and identify lipid targets of PQQ. PQQ exposure during pregnancy altered
ST:STUDY_SUMMARY                 	hepatic lipid profiles of WD-exposed offspring, upregulating peroxisome
ST:STUDY_SUMMARY                 	proliferator-activated receptor (PPAR) α signaling and mitochondrial fatty acid
ST:STUDY_SUMMARY                 	oxidation to markedly attenuate triglyceride accumulation beginning in utero.
ST:STUDY_SUMMARY                 	Surprisingly, the abundance of very long-chain ceramides, important in promoting
ST:STUDY_SUMMARY                 	gut barrier and hepatic function, was significantly elevated in PQQ-treated
ST:STUDY_SUMMARY                 	offspring. PQQ exposure reduced the hepatic
ST:STUDY_SUMMARY                 	phosphatidylcho-line/phosphatidylethanolamine (PC/PE) ratio in WD-fed offspring
ST:STUDY_SUMMARY                 	and improved glucose toler-ance. Notably, levels of protective n − 3
ST:STUDY_SUMMARY                 	polyunsaturated fatty acids (PUFAs) were elevated in offspring exposed to PQQ,
ST:STUDY_SUMMARY                 	beginning in utero, and the increase in n − 3 PUFAs persisted into adulthood.
ST:STUDY_SUMMARY                 	Our findings suggest that PQQ supplementation during gestation and lactation
ST:STUDY_SUMMARY                 	augments pathways involved in the biosynthesis of long-chain fatty acids and
ST:STUDY_SUMMARY                 	plays a unique role in modifying specific bioactive lipid species critical for
ST:STUDY_SUMMARY                 	protection against NAFLD risk in later life.
ST:INSTITUTE                     	University of Oklahoma Health Sciences Center
ST:DEPARTMENT                    	Biochemistry and Molecular Biology, Harold Hamm Diabetes Center
ST:LABORATORY                    	Jonscher
ST:LAST_NAME                     	Jonscher
ST:FIRST_NAME                    	Karen
ST:ADDRESS                       	975 NE 10th Street BRC-N 362A, Oklahoma City, OK, 73104, USA
ST:EMAIL                         	karen-jonscher@ouhsc.edu
ST:PHONE                         	3032294620
ST:NUM_GROUPS                    	4
ST:TOTAL_SUBJECTS                	24
ST:NUM_MALES                     	24
ST:PUBLICATIONS                  	Jonscher, et al FASEB J 2017; Friedman, et al Hepatol Commun 2018
#SUBJECT
SU:SUBJECT_TYPE                  	Mammal
SU:SUBJECT_SPECIES               	Mus musculus
SU:TAXONOMY_ID                   	10090
SU:AGE_OR_AGE_RANGE              	20-24 weeks
SU:GENDER                        	Male
SU:ANIMAL_HOUSING                	Vivarium University of Colorado Anschutz Medical Campus
SU:ANIMAL_LIGHT_CYCLE            	12/12
SU:ANIMAL_FEED                   	CH; 2019; Envigo, Indianapolis, IN or .D  TD.88137; Envigo
SU:ANIMAL_WATER                  	Water or treated with 1.25 mg/L PQQ
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	-	1991A	Diet:CTL	
SUBJECT_SAMPLE_FACTORS           	-	1991B	Diet:CTL	
SUBJECT_SAMPLE_FACTORS           	-	1991C	Diet:CTL	
SUBJECT_SAMPLE_FACTORS           	-	1996A	Diet:CTL	
SUBJECT_SAMPLE_FACTORS           	-	1996B	Diet:CTL	
SUBJECT_SAMPLE_FACTORS           	-	1996C	Diet:CTL	
SUBJECT_SAMPLE_FACTORS           	-	1990A	Diet:CTL	
SUBJECT_SAMPLE_FACTORS           	-	1990B	Diet:CTL	
SUBJECT_SAMPLE_FACTORS           	-	1990C	Diet:CTL	
SUBJECT_SAMPLE_FACTORS           	-	5329C	Diet:CTL	
SUBJECT_SAMPLE_FACTORS           	-	5329A	Diet:CTL	
SUBJECT_SAMPLE_FACTORS           	-	5329B	Diet:CTL	
SUBJECT_SAMPLE_FACTORS           	-	389A	Diet:CTL PQQ	
SUBJECT_SAMPLE_FACTORS           	-	389B	Diet:CTL PQQ	
SUBJECT_SAMPLE_FACTORS           	-	389C	Diet:CTL PQQ	
SUBJECT_SAMPLE_FACTORS           	-	330A	Diet:CTL PQQ	
SUBJECT_SAMPLE_FACTORS           	-	330B	Diet:CTL PQQ	
SUBJECT_SAMPLE_FACTORS           	-	330C	Diet:CTL PQQ	
SUBJECT_SAMPLE_FACTORS           	-	358A	Diet:CTL PQQ	
SUBJECT_SAMPLE_FACTORS           	-	358B	Diet:CTL PQQ	
SUBJECT_SAMPLE_FACTORS           	-	358C	Diet:CTL PQQ	
SUBJECT_SAMPLE_FACTORS           	-	333A	Diet:CTL PQQ	
SUBJECT_SAMPLE_FACTORS           	-	333B	Diet:CTL PQQ	
SUBJECT_SAMPLE_FACTORS           	-	333C	Diet:CTL PQQ	
SUBJECT_SAMPLE_FACTORS           	-	362A	Diet:CTL PQQ	
SUBJECT_SAMPLE_FACTORS           	-	362B	Diet:CTL PQQ	
SUBJECT_SAMPLE_FACTORS           	-	362C	Diet:CTL PQQ	
SUBJECT_SAMPLE_FACTORS           	-	754A	Diet:WD	
SUBJECT_SAMPLE_FACTORS           	-	754B	Diet:WD	
SUBJECT_SAMPLE_FACTORS           	-	754C	Diet:WD	
SUBJECT_SAMPLE_FACTORS           	-	1007A	Diet:WD	
SUBJECT_SAMPLE_FACTORS           	-	1007B	Diet:WD	
SUBJECT_SAMPLE_FACTORS           	-	1007C	Diet:WD	
SUBJECT_SAMPLE_FACTORS           	-	5328B	Diet:WD	
SUBJECT_SAMPLE_FACTORS           	-	5328C	Diet:WD	
SUBJECT_SAMPLE_FACTORS           	-	5328A	Diet:WD	
SUBJECT_SAMPLE_FACTORS           	-	372A	Diet:WD	
SUBJECT_SAMPLE_FACTORS           	-	372B	Diet:WD	
SUBJECT_SAMPLE_FACTORS           	-	372C	Diet:WD	
SUBJECT_SAMPLE_FACTORS           	-	386A	Diet:WD	
SUBJECT_SAMPLE_FACTORS           	-	386B	Diet:WD	
SUBJECT_SAMPLE_FACTORS           	-	386C	Diet:WD	
SUBJECT_SAMPLE_FACTORS           	-	361A	Diet:WD	
SUBJECT_SAMPLE_FACTORS           	-	361B	Diet:WD	
SUBJECT_SAMPLE_FACTORS           	-	361C	Diet:WD	
SUBJECT_SAMPLE_FACTORS           	-	989C	Diet:WD	
SUBJECT_SAMPLE_FACTORS           	-	989A	Diet:WD	
SUBJECT_SAMPLE_FACTORS           	-	989B	Diet:WD	
SUBJECT_SAMPLE_FACTORS           	-	773A	Diet:WD PQQ	
SUBJECT_SAMPLE_FACTORS           	-	773B	Diet:WD PQQ	
SUBJECT_SAMPLE_FACTORS           	-	773C	Diet:WD PQQ	
SUBJECT_SAMPLE_FACTORS           	-	768A	Diet:WD PQQ	
SUBJECT_SAMPLE_FACTORS           	-	768B	Diet:WD PQQ	
SUBJECT_SAMPLE_FACTORS           	-	768C	Diet:WD PQQ	
SUBJECT_SAMPLE_FACTORS           	-	901A	Diet:WD PQQ	
SUBJECT_SAMPLE_FACTORS           	-	901B	Diet:WD PQQ	
SUBJECT_SAMPLE_FACTORS           	-	901C	Diet:WD PQQ	
SUBJECT_SAMPLE_FACTORS           	-	767A	Diet:WD PQQ	
SUBJECT_SAMPLE_FACTORS           	-	767B	Diet:WD PQQ	
SUBJECT_SAMPLE_FACTORS           	-	767C	Diet:WD PQQ	
SUBJECT_SAMPLE_FACTORS           	-	703A	Diet:WD PQQ	
SUBJECT_SAMPLE_FACTORS           	-	703B	Diet:WD PQQ	
SUBJECT_SAMPLE_FACTORS           	-	703C	Diet:WD PQQ	
SUBJECT_SAMPLE_FACTORS           	-	756A	Diet:WD PQQ	
SUBJECT_SAMPLE_FACTORS           	-	756B	Diet:WD PQQ	
SUBJECT_SAMPLE_FACTORS           	-	756C	Diet:WD PQQ	
SUBJECT_SAMPLE_FACTORS           	-	179A	Diet:WD PQQ/WD	
SUBJECT_SAMPLE_FACTORS           	-	179B	Diet:WD PQQ/WD	
SUBJECT_SAMPLE_FACTORS           	-	179C	Diet:WD PQQ/WD	
SUBJECT_SAMPLE_FACTORS           	-	181A	Diet:WD PQQ/WD	
SUBJECT_SAMPLE_FACTORS           	-	181B	Diet:WD PQQ/WD	
SUBJECT_SAMPLE_FACTORS           	-	181C	Diet:WD PQQ/WD	
SUBJECT_SAMPLE_FACTORS           	-	743A	Diet:WD PQQ/WD	
SUBJECT_SAMPLE_FACTORS           	-	743B	Diet:WD PQQ/WD	
SUBJECT_SAMPLE_FACTORS           	-	743C	Diet:WD PQQ/WD	
SUBJECT_SAMPLE_FACTORS           	-	739A	Diet:WD PQQ/WD	
SUBJECT_SAMPLE_FACTORS           	-	739B	Diet:WD PQQ/WD	
SUBJECT_SAMPLE_FACTORS           	-	739C	Diet:WD PQQ/WD	
SUBJECT_SAMPLE_FACTORS           	-	727A	Diet:WD PQQ/WD	
SUBJECT_SAMPLE_FACTORS           	-	727B	Diet:WD PQQ/WD	
SUBJECT_SAMPLE_FACTORS           	-	727C	Diet:WD PQQ/WD	
SUBJECT_SAMPLE_FACTORS           	-	766A	Diet:WD PQQ/WD	
SUBJECT_SAMPLE_FACTORS           	-	766B	Diet:WD PQQ/WD	
SUBJECT_SAMPLE_FACTORS           	-	766C	Diet:WD PQQ/WD	
#COLLECTION
CO:COLLECTION_SUMMARY            	Livers were excised and snap frozen then 10-15 mg aliquots sent to the West
CO:COLLECTION_SUMMARY            	Coast Metabolomics Center for analysis following standard protocols.
CO:SAMPLE_TYPE                   	Liver
CO:STORAGE_CONDITIONS            	-80℃
CO:COLLECTION_VIALS              	Cryotubes
CO:STORAGE_VIALS                 	Cryotubes
#TREATMENT
TR:TREATMENT_SUMMARY             	Dams and offspring were fed either chow (CH) or western-style diet (WD), with or
TR:TREATMENT_SUMMARY             	without PQQ in drinking water. A subset of WD-exposed offspring were weaned onto
TR:TREATMENT_SUMMARY             	WD without PQQ.
TR:TREATMENT                     	WD and PQQ
TR:TREATMENT_COMPOUND            	BioPQQ
TR:TREATMENT_ROUTE               	Drinking water, ad libitem
TR:TREATMENT_DOSE                	1.25 mg/L
TR:TREATMENT_DOSEDURATION        	17-21 weeks
TR:TREATMENT_VEHICLE             	drinking water
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	Tissue was homogenized and lipids extracted following standard protocols at the
SP:SAMPLEPREP_SUMMARY            	WCMC. Samples were prepared in triplicate
SP:SAMPLEPREP_PROTOCOL_FILENAME  	SP_Extraction_Protocol_for_liver_multi-omic.pdf
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
CH:INSTRUMENT_NAME               	Agilent 1200
CH:COLUMN_NAME                   	Waters Acquity CSH C18 (100 x 2.1mm, 1.7um)
CH:METHODS_FILENAME              	SOP_Lipidomic_Analysis_by_UPLC_QTOF.pdf
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
AN:ANALYSIS_PROTOCOL_FILE        	SOP_Lipidomic_Analysis_by_UPLC_QTOF.pdf
#MS
MS:INSTRUMENT_NAME               	Agilent 6530 QTOF
MS:INSTRUMENT_TYPE               	QTOF
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	NEGATIVE
MS:MS_COMMENTS                   	See attached file
MS:MS_RESULTS_FILE               	ST002192_AN003588_Results.txt	UNITS:Peak area	Has m/z:Yes	Has RT:Yes	RT units:Minutes
#END